Enhancing thrombolytic efficacy by means of "front-loaded" administration of tissue plasminogen activator.
Braunwald
E
E
Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115.
D003327:Coronary Disease / Q000188:drug therapy* / Q000401:mortality; D004334:Drug Administration Schedule; D006801:Humans; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage* / Q000009:adverse effects; D014654:Vascular Patency / Q000187:drug effects
D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator